Showing results (1431-1440 of 1,985) with videos related to
Sort By:
Pageof 199
The Lancet. Neurology|May 3, 2015
Lumboperitoneal shunt surgery for idiopathic normal pressure hydrocephalus (SINPHONI-2): an open-label randomised trialHiroaki Kazui, Masakazu Miyajima, Etsuro Mori, et al.The Lancet. Neurology|March 12, 2023
Thrombolysis for acute ischaemic stroke: current status and future perspectivesGeorgios Tsivgoulis, Aristeidis H Katsanos, Else Charlotte Sandset, et al.The Lancet. Neurology|March 17, 2023
Safety and efficacy of pitolisant in children aged 6 years or older with narcolepsy with or without cataplexy: a double-blind, randomised, placebo-controlled trialYves Dauvilliers, Michel Lecendreux, Gert Jan Lammers, et al.The Lancet. Neurology|March 17, 2023
Effect of atherosclerosis on 5-year risk of major vascular events in patients with transient ischaemic attack or minor ischaemic stroke: an international prospective cohort studyPhilippa C Lavallée, Hugo Charles, Gregory W Albers, et al.The Lancet. Neurology|March 17, 2023
Family planning considerations in people with multiple sclerosisKristen M Krysko, Ruth Dobson, Raed Alroughani, et al.The Lancet. Neurology|January 27, 2023
Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteriaBrenda Banwell, Jeffrey L Bennett, Romain Marignier, et al.The Lancet. Neurology|January 24, 2026
Herpes zoster vaccination and incident dementia in Canada: an analysis of natural experimentsMichael Pomirchy, Seunghun Chung, Christian Bommer, et al.The Lancet. Neurology|February 10, 2023
Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapyFrancesca Aloisi, Gavin Giovannoni, Marco SalvettiThe Lancet. Neurology|February 21, 2023
Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trialCharles A Thornton, Richard Thomas Moxley, Katy Eichinger, et al.The Lancet. Neurology|March 20, 2010
Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable conditionJean-Michel Vallat, Claudia Sommer, Laurent MagyPageof 199